|
37675613 |
0 |
Field TS, Dizonno V, Almekhlafi MA, et al.
Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis.
Stroke. 2023 Sep 7. doi: 10.1161/STROKEAHA.123.044113.
|
|
34940092 |
0 |
Carrier M, Blais N, Crowther M, et al.
Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus.
Curr Oncol. 2021 Dec 18;28(6):5434-5451. doi: 10.3390/curroncol28060453.
|
|
34649864 |
0 |
Sholzberg M, Tang GH, Rahhal H, et al.
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial.
BMJ. 2021 Oct 14;375:n2400. doi: 10.1136/bmj.n2400.
|
|
31382307 |
0 |
Suryanarayan D, Lee AYY, Wu C.
Direct Oral Anticoagulants in Cancer Patients.
Semin Thromb Hemost. 2019 Sep;45(6):638-647. doi: 10.1055/s-0039-1693479. Epub 2019 Aug 5.
|